Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Mar 30:12:855075.
doi: 10.3389/fcimb.2022.855075. eCollection 2022.

Gut Microbiota: The Potential Key Target of TCM's Therapeutic Effect of Treating Different Diseases Using the Same Method-UC and T2DM as Examples

Affiliations
Review

Gut Microbiota: The Potential Key Target of TCM's Therapeutic Effect of Treating Different Diseases Using the Same Method-UC and T2DM as Examples

Boxun Zhang et al. Front Cell Infect Microbiol. .

Abstract

Traditional Chinese herbal medicine often exerts the therapeutic effect of "treating different diseases with the same method" in clinical practice; in other words, it is a kind of herbal medicine that can often treat two or even multiple diseases; however, the biological mechanism underlying its multi-path and multi-target pharmacological effects remains unclear. Growing evidence has demonstrated that gut microbiota dysbiosis plays a vital role in the occurrence and development of several diseases, and that the root cause of herbal medicine plays a therapeutic role in different diseases, a phenomenon potentially related to the improvement of the gut microbiota. We used local intestinal diseases, such as ulcerative colitis, and systemic diseases, such as type 2 diabetes, as examples; comprehensively searched databases, such as PubMed, Web of Science, and China National Knowledge Infrastructure; and summarized the related studies. The results indicate that multiple individual Chinese herbal medicines, such as Rhizoma coptidis (Huang Lian), Curcuma longa L (Jiang Huang), and Radix Scutellariae (Huang Qin), and Chinese medicinal compounds, such as Gegen Qinlian Decoction, Banxia Xiexin Decoction, and Shenling Baizhu Powder, potentially treat these two diseases by enriching the diversity of the gut microbiota, increasing beneficial bacteria and butyrate-producing bacteria, reducing pathogenic bacteria, improving the intestinal mucosal barrier, and inhibiting intestinal and systemic inflammation. In conclusion, this study found that a variety of traditional Chinese herbal medicines can simultaneously treat ulcerative colitis and type 2 diabetes, and the gut microbiota may be a significant target for herbal medicine as it exerts its therapeutic effect of "treating different diseases with the same method".

Keywords: diabetes mellitus; gut microbiota; inflammation.; intestinal barrier; ulcerative colitis.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
TCM’s therapeutic effect of treating UC and T2DM using the same method. TCM, traditional Chinese medicine; UC, ulcerative colitis; T2DM, type 2 diabetes mellitus; LPS, lipopolysaccharide; SCFAs, short chain fatty acids; BAs, bile acids; Trp, tryptophan.

Similar articles

Cited by

References

    1. Abenavoli L., Scarpellini E., Colica C., Boccuto L., Salehi B., Sharifi-Rad J., et al. (2019). Gut Microbiota and Obesity: A Role for Probiotics. Nutrients 11, 2690. doi: 10.3390/nu11112690 - DOI - PMC - PubMed
    1. Agus A., Planchais J., Sokol H. (2018). Gut Microbiota Regulation of Tryptophan Metabolism in Health and Disease. Cell Host Microbe 23 (6), 716–724. doi: 10.1016/j.chom.2018.05.003 - DOI - PubMed
    1. Amyot J., Semache M., Ferdaoussi M., Fontés G., Poitout V. (2012). Lipopolysaccharides Impair Insulin Gene Expression in Isolated Islets of Langerhans via Toll-Like Receptor-4 and NF-κb Signalling. PloS One 7, e36200. doi: 10.1371/journal.pone.0036200 - DOI - PMC - PubMed
    1. Ananthakrishnan A. N. (2015). Epidemiology and Risk Factors for IBD. Nature Reviews. Gastroenterol. Hepatol. 12, 205–217. doi: 10.1038/nrgastro.2015.34 - DOI - PubMed
    1. Arafa E. A., Mohamed W. R., Zaher D. M., Omar H. A. (2020). Gliclazide Attenuates Acetic Acid-Induced Colitis via the Modulation of Pparγ, NF-κb and MAPK Signaling Pathways. Toxicol. Appl. Pharmacol. 391, 114919. doi: 10.1016/j.taap.2020.114919 - DOI - PubMed

Publication types

MeSH terms

Substances